a year ago

PolyModels Hub Secures £1.1 Million to Digitize Pharmaceutical Process Development

  • PolyModels Hub, an English biotech software platform, has raised £1.1 million in Seed funding from Marathon Venture Capital

  • The company aims to revolutionize pharmaceutical process development by digitizing the archaic processes and lagging adoption of digital tools in the industry

  • PolyModels Hub leverages AI and advanced technology to digitally design and run in-silico simulations for new and existing medicines, accelerating time to market and saving millions in process development costs

  • The company has already partnered with leading pharmaceutical companies and aims to build the digital backbone for pharma process development, providing a platform for scientists to research, collaborate, build, and manage their drug portfolios.

      • ProblemTechnology

      "Pharmaceutical process development, a critical part of bringing a new drug to market, relies heavily on outdated processes and manual methods, leading to expensive and time-consuming development cycles. Scientists still rely heavily on past experience and empirical knowledge, leading to limited knowledge transfer between projects and a lack of efficient collaboration and data management."

      Solution

      "PolyModels Hub offers a digital platform designed specifically for pharmaceutical process development. This platform uses AI and simulation technology to model and analyze various aspects of the drug development process, allowing for improved efficiency, faster time to market, and reduced costs. The platform also facilitates collaboration among scientists, allowing for better knowledge sharing and data management."

      Covered on